MiR-133a acts as an anti-oncogene in Hepatocellular carcinoma by inhibiting FOSL2 through TGF-β/Smad3 signaling pathway
| Autor: | Sun, Lu, Guo, Zhixian, Sun, Jihong, Li, Jingjing, Dong, Zihui, Zhang, Yize, Chen, Jianan, Kan, Quancheng, Yu, Zujiang |
|---|---|
| Zdroj: | In Biomedicine & Pharmacotherapy November 2018 107:168-176 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect